Mazzini L - Search Results

1

Early symptom progression rate is related to ALS outcome: a prospective population-based study.

Chiò A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, Bottacchi E, Mutani R; Piemonte and Valle d'Aosta Register for ALS (PARALS). Chiò A, et al. Among authors: mazzini l. Neurology. 2002 Jul 9;59(1):99-103. doi: 10.1212/wnl.59.1.99. Neurology. 2002. PMID: 12105314

2

A follow-up electromyographic investigation of ALS patients treated with high dosage gangliosides.

Pinelli P, Mazzini L, Mora G, Pisano F, Villani A. Pinelli P, et al. Among authors: mazzini l. Adv Exp Med Biol. 1987;209:285-91. doi: 10.1007/978-1-4684-5302-7_41. Adv Exp Med Biol. 1987. PMID: 3577919 No abstract available.

3

An open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis.

Mazzini L, Testa D, Balzarini C, Mora G. Mazzini L, et al. J Neurol. 1994 Feb;241(4):223-7. doi: 10.1007/BF00863772. J Neurol. 1994. PMID: 8195821 Clinical Trial.

4

Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis.

Mazzini L, Corrà T, Zaccala M, Mora G, Del Piano M, Galante M. Mazzini L, et al. J Neurol. 1995 Oct;242(10):695-8. doi: 10.1007/BF00866922. J Neurol. 1995. PMID: 8568533

5

Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes.

Curti D, Malaspina A, Facchetti G, Camana C, Mazzini L, Tosca P, Zerbi F, Ceroni M. Curti D, et al. Among authors: mazzini l. Neurology. 1996 Oct;47(4):1060-4. doi: 10.1212/wnl.47.4.1060. Neurology. 1996. PMID: 8857745

6

The natural history and the effects of gabapentin in amyotrophic lateral sclerosis.

Mazzini L, Mora G, Balzarini C, Brigatti M, Pirali I, Comazzi F, Pastore E. Mazzini L, et al. J Neurol Sci. 1998 Oct;160 Suppl 1:S57-63. doi: 10.1016/s0022-510x(98)00199-3. J Neurol Sci. 1998. PMID: 9851651 Clinical Trial.

7

Motor neuron disease: usefulness of transcranial magnetic stimulation in improving the diagnosis.

Miscio G, Pisano F, Mora G, Mazzini L. Miscio G, et al. Among authors: mazzini l. Clin Neurophysiol. 1999 May;110(5):975-81. doi: 10.1016/s1388-2457(99)00030-9. Clin Neurophysiol. 1999. PMID: 10400213

8

A randomized controlled trial of recombinant interferon beta-1a in ALS. Italian Amyotrophic Lateral Sclerosis Study Group.

Beghi E, Chiò A, Inghilleri M, Mazzini L, Micheli A, Mora G, Poloni M, Riva R, Serlenga L, Testa D, Tonali P. Beghi E, et al. Among authors: mazzini l. Neurology. 2000 Jan 25;54(2):469-74. doi: 10.1212/wnl.54.2.469. Neurology. 2000. PMID: 10668716 Clinical Trial.

9

Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis.

Poloni M, Facchetti D, Mai R, Micheli A, Agnoletti L, Francolini G, Mora G, Camana C, Mazzini L, Bachetti T. Poloni M, et al. Among authors: mazzini l. Neurosci Lett. 2000 Jun 30;287(3):211-4. doi: 10.1016/s0304-3940(00)01177-0. Neurosci Lett. 2000. PMID: 10863032

10

Measurement of isometric muscle strength: a reproducibility study of maximal voluntary contraction in normal subjects and amyotrophic lateral sclerosis patients.

Colombo R, Mazzini L, Mora G, Parenzan R, Creola G, Pirali I, Minuco G. Colombo R, et al. Among authors: mazzini l. Med Eng Phys. 2000 Apr;22(3):167-74. doi: 10.1016/s1350-4533(00)00024-2. Med Eng Phys. 2000. PMID: 10964037 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters